These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11997871)

  • 1. [Adverse drug reactions. Hereditary differences in drug metabolism].
    Collette D; Thürmann PA
    Dtsch Med Wochenschr; 2002 May; 127(19):1025-8. PubMed ID: 11997871
    [No Abstract]   [Full Text] [Related]  

  • 2. Bench to bedside: Pharmacogenomics, adverse drug interactions, and the cytochrome P450 system.
    Sikka R; Magauran B; Ulrich A; Shannon M
    Acad Emerg Med; 2005 Dec; 12(12):1227-35. PubMed ID: 16282513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylator status, drug metabolism and disease.
    Pande JN; Pande A; Singh SP
    Natl Med J India; 2003; 16(1):24-6. PubMed ID: 12715953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacogenetics and pharmacogenomics. Searching for individual antihypertensive therapy concepts].
    Brand E
    MMW Fortschr Med; 2003 May; 145(19):43-4. PubMed ID: 12813978
    [No Abstract]   [Full Text] [Related]  

  • 5. [Polymorphism of enzymes involved in drug metabolism: gene structure and enzymatic activity].
    Krynetskiĭ EI
    Mol Biol (Mosk); 1996; 30(1):33-42. PubMed ID: 8714120
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic polymorphisms of drug metabolism.
    Meyer UA; Zanger UM; Skoda RC; Grant D; Blum M
    Prog Liver Dis; 1990; 9():307-23. PubMed ID: 2156298
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical individuality and its implications for drug and carcinogen metabolism: recent insights from acetyltransferase and cytochrome P4501A2 phenotyping and genotyping in humans.
    Kadlubar FF
    Drug Metab Rev; 1994; 26(1-2):37-46. PubMed ID: 8082575
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
    Lynch T; Price A
    Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic tests give the finishing touch to individual drug dosage].
    Sjöqvist F
    Lakartidningen; 2003 Feb; 100(8):592-3. PubMed ID: 12640970
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic basis of toxic reactions to drugs and chemicals.
    Cascorbi I
    Toxicol Lett; 2006 Mar; 162(1):16-28. PubMed ID: 16310984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of genetic polymorphisms in risk assessment of drugs.
    Poulsen HE; Loft S
    Arch Toxicol Suppl; 1994; 16():211-22. PubMed ID: 8192584
    [No Abstract]   [Full Text] [Related]  

  • 12. [Adverse effects and drug interactions].
    Perlík F
    Cas Lek Cesk; 2004; 143(2):110-3. PubMed ID: 15077574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics of cytotoxic drugs.
    Daly AK; Hall AG
    Expert Rev Anticancer Ther; 2001 Aug; 1(2):301-8. PubMed ID: 12113035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in drug-metabolizing enzymes: what is their clinical relevance and why do they exist?
    Nebert DW
    Am J Hum Genet; 1997 Feb; 60(2):265-71. PubMed ID: 9012398
    [No Abstract]   [Full Text] [Related]  

  • 15. [Metabolism of drugs. III. Genetic factors inducing and inhibiting metabolism].
    Dyderski S; Grzymisławski M
    Pol Merkur Lekarski; 2005 Apr; 18(106):457-61. PubMed ID: 16161934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polymorphism of arylamine-N-acetyltransferase 2 gene in peoples of the Volga-Ural region].
    Viktorova TV; Korytina GF; Makarova OV; Ianbaeva DG; Iakupova EV; Shangareeva ZA; Khusnutdinova EK
    Mol Biol (Mosk); 2003; 37(6):971-4. PubMed ID: 14714491
    [No Abstract]   [Full Text] [Related]  

  • 17. N-Acetyltransferase-1 gene polymorphisms and correlation between genotype and its activity in a central Chinese Han population.
    Zhangwei X; Jianming X; Qiao M; Xinhua X
    Clin Chim Acta; 2006 Sep; 371(1-2):85-91. PubMed ID: 16600204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: The prevalence and clinical relevance of cytochrome P450 polymorphisms.
    Wijnen PA; Op den Buijsch RA; Drent M; Kuijpers PM; Neef C; Bast A; Bekers O; Koek GH
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():211-9. PubMed ID: 18081664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAT2 gene polymorphism: covert drug interaction causing phenytoin toxicity.
    Adithan C; Subathra A
    Indian J Med Res; 2016 May; 143(5):542-4. PubMed ID: 27487996
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic polymorphisms of cytochrome P450 enzymes and the effect on interindividual, pharmacokinetic variability in extensive metabolizers.
    Ma JD; Nafziger AN; Bertino JS
    J Clin Pharmacol; 2004 May; 44(5):447-56. PubMed ID: 15102864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.